![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: NCALD |
Gene summary for NCALD |
![]() |
Gene information | Species | Human | Gene symbol | NCALD | Gene ID | 83988 |
Gene name | neurocalcin delta | |
Gene Alias | NCALD | |
Cytomap | 8q22.3 | |
Gene Type | protein-coding | GO ID | GO:0003008 | UniProtAcc | B2RB70 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
83988 | NCALD | AEH-subject1 | Human | Endometrium | AEH | 1.14e-22 | 6.36e-01 | -0.3059 |
83988 | NCALD | AEH-subject2 | Human | Endometrium | AEH | 4.93e-20 | 6.29e-01 | -0.2525 |
83988 | NCALD | AEH-subject3 | Human | Endometrium | AEH | 3.31e-02 | 2.43e-01 | -0.2576 |
83988 | NCALD | AEH-subject4 | Human | Endometrium | AEH | 1.74e-14 | 5.68e-01 | -0.2657 |
83988 | NCALD | AEH-subject5 | Human | Endometrium | AEH | 2.93e-36 | 9.65e-01 | -0.2953 |
83988 | NCALD | EEC-subject1 | Human | Endometrium | EEC | 4.21e-36 | 8.77e-01 | -0.2682 |
83988 | NCALD | EEC-subject2 | Human | Endometrium | EEC | 6.16e-27 | 7.44e-01 | -0.2607 |
83988 | NCALD | EEC-subject4 | Human | Endometrium | EEC | 7.81e-35 | 9.39e-01 | -0.2571 |
83988 | NCALD | EEC-subject5 | Human | Endometrium | EEC | 3.89e-32 | 7.77e-01 | -0.249 |
83988 | NCALD | GSM5276935 | Human | Endometrium | EEC | 2.57e-09 | 3.71e-01 | -0.123 |
83988 | NCALD | GSM6177621_NYU_UCEC2_lib1_lib1 | Human | Endometrium | EEC | 4.73e-04 | 2.97e-01 | -0.1934 |
83988 | NCALD | GSM6177622_NYU_UCEC3_lib1_lib1 | Human | Endometrium | EEC | 9.87e-06 | 1.53e-01 | -0.1917 |
83988 | NCALD | P5T-E | Human | Esophagus | ESCC | 4.01e-04 | 4.90e-02 | 0.1327 |
83988 | NCALD | P16T-E | Human | Esophagus | ESCC | 2.03e-23 | 8.57e-01 | 0.1153 |
83988 | NCALD | P26T-E | Human | Esophagus | ESCC | 8.07e-04 | 2.20e-01 | 0.1276 |
83988 | NCALD | P27T-E | Human | Esophagus | ESCC | 8.33e-09 | 3.57e-01 | 0.1055 |
83988 | NCALD | P37T-E | Human | Esophagus | ESCC | 3.26e-04 | 4.21e-02 | 0.1371 |
83988 | NCALD | P40T-E | Human | Esophagus | ESCC | 5.11e-06 | 1.58e-01 | 0.109 |
83988 | NCALD | P54T-E | Human | Esophagus | ESCC | 2.64e-03 | 1.50e-01 | 0.0975 |
83988 | NCALD | P61T-E | Human | Esophagus | ESCC | 2.34e-02 | 3.35e-02 | 0.099 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | CRC | ![]() |
Stomach | GC | ![]() |
Stomach | CAG with IM | ![]() |
Stomach | CSG | ![]() |
Stomach | CAG | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0019932 | Lung | AIS | second-messenger-mediated signaling | 46/1849 | 312/18723 | 3.79e-03 | 3.52e-02 | 46 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
NCALD | SNV | Missense_Mutation | novel | c.255N>A | p.Phe85Leu | p.F85L | P61601 | protein_coding | deleterious(0) | probably_damaging(0.989) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
NCALD | SNV | Missense_Mutation | novel | c.76G>A | p.Glu26Lys | p.E26K | P61601 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-VS-A94X-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
NCALD | SNV | Missense_Mutation | c.111N>A | p.Asp37Glu | p.D37E | P61601 | protein_coding | tolerated(0.11) | benign(0.023) | TCGA-AA-A02W-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
NCALD | SNV | Missense_Mutation | novel | c.493N>C | p.Ser165Pro | p.S165P | P61601 | protein_coding | deleterious(0) | probably_damaging(0.985) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
NCALD | SNV | Missense_Mutation | novel | c.235N>G | p.Thr79Ala | p.T79A | P61601 | protein_coding | tolerated(0.29) | benign(0.129) | TCGA-F5-6814-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
NCALD | insertion | Frame_Shift_Ins | novel | c.117dupC | p.Ser40GlnfsTer10 | p.S40Qfs*10 | P61601 | protein_coding | TCGA-D5-6930-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | ||
NCALD | SNV | Missense_Mutation | novel | c.542G>A | p.Arg181His | p.R181H | P61601 | protein_coding | deleterious(0.04) | possibly_damaging(0.465) | TCGA-AJ-A8CW-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
NCALD | SNV | Missense_Mutation | novel | c.401N>A | p.Ser134Tyr | p.S134Y | P61601 | protein_coding | deleterious(0) | benign(0.022) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
NCALD | SNV | Missense_Mutation | novel | c.241G>T | p.Asp81Tyr | p.D81Y | P61601 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-AP-A1DV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
NCALD | SNV | Missense_Mutation | novel | c.414N>A | p.Met138Ile | p.M138I | P61601 | protein_coding | tolerated(0.07) | benign(0.007) | TCGA-AX-A06F-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |